- Preview Available
- Scholarly Journal
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial
NPJ Precision Oncology; London Vol. 9, Iss. 1, (2025): 86.
DOI:10.1038/s41698-025-00874-0
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.





